Analysis of Epstein–Barr Virus and Tumor‐Derived Circulating Plasma DNA in Children and Young Adults With Classical Hodgkin Lymphoma in East Africa
- 28 September 2026
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- p. e70710
Abstract
Background: Pediatric Hodgkin lymphoma in sub‐Saharan Africa is frequently associated with Epstein–Barr virus (EBV), providing a unique opportunity to investigate the molecular characteristics and clinical significance of EBV‐associated disease in an understudied population. Procedures: We conducted an observational cohort study of 50 children and young adults with newly diagnosed classical Hodgkin lymphoma (cHL) in Tanzania and Uganda. Plasma cell‐free DNA collected at diagnosis was analyzed for circulating tumor DNA (ctDNA), EBV‐derived biomarkers, and somatic mutations. Associations between clinical, molecular, and survival outcomes were assessed using correlation analyses and Cox proportional hazards models. Results: The median age was 12 years and 62% of participants were male. Most patients presented with advanced‐stage disease. ctDNA was detected in 60% of patients with a low mutational burden, while EBV DNA was detected in 92% of cases. Male patients exhibited higher EBV‐derived markers and fewer TNFAIP3 and B2M mutations. At a median follow‐up of 17.2 months, overall survival was 84% and event‐free survival was 50%; male sex and elevated lactate dehydrogenase independently predicted inferior event‐free survival. Conclusions: These findings reveal a low mutational burden and sex‐associated molecular and clinical differences in EBV‐positive cHL.Keywords
This publication has 16 references indexed in Scilit:
- Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adultsHemaSphere, 2026
- A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNABlood, 2025
- Childhood Hodgkin Lymphoma in Sub-Saharan Africa: A Systematic Review on the Effectiveness of the Use of Chemotherapy AloneGlobal Pediatric Health, 2024
- An update on molecular features and therapeutic perspectives of pediatric classical Hodgkin Lymphoma. What the clinician needs to know?European Journal of Medical Genetics, 2022
- The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15‐ICML workshop on ctDNAHematological Oncology, 2019
- Calling Somatic SNVs and Indels with Mutect2bioRxiv, 2019
- Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinomaProceedings of the National Academy of Sciences, 2018
- Hodgkin lymphoma in Africa: Present and futureTransfusion and Apheresis Science, 2013
- TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaJournal of Experimental Medicine, 2009
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998